Swapping sugary drinks for coffee, tea or water linked to fewer deaths in adults with diabetes

Findings highlight role of healthy beverage choices to manage risk, say researchers  For adults with type 2 diabetes, replacing sugary drinks with coffee, tea, or plain water is linked to lower rates of early death due to cardiovascular disease (CVD) and other causes, finds research published by The BMJ. A greater ...

2024-06-04T10:24:09+00:0024 April 2023|Press release, The BMJ|

Female healthworkers need better radiation protection to minimise breast cancer risk

Standard PPE does not fully protect breast tissue Employers should invest in equipment that ensures the safety of all their staff Women working in healthcare who are regularly exposed to radiation from x-rays and other imaging procedures need better ionising radiation protection to help minimise their risk of developing breast cancer, argue ...

2024-06-04T10:23:06+00:0013 April 2023|Press release, The BMJ|

Limit added sugar to six teaspoons a day to improve health, urge experts

Evidence review finds harmful links between excess sugar intake and 45 outcomes including diabetes, depression, obesity and heart disease Experts recommend reducing consumption of added (“free”) sugars to around six teaspoons a day and limiting sugar-sweetened drinks to less than one serving a week after a comprehensive evidence review published ...

2024-06-04T10:24:10+00:006 April 2023|Press release, The BMJ|

Benefits of Mediterranean and low fat diet programmes in patients at risk of cardiovascular disease

Seven dietary programmes compared; Mediterranean programmes also likely to reduce stroke risk, say researchers Mediterranean and low fat dietary programmes reduce the likelihood of death and heart attack in patients at heightened risk of cardiovascular disease, finds the first comparative review based on randomised trials of seven popular dietary programmes published by The BMJ today. Dietary ...

2024-06-04T10:24:10+00:0030 March 2023|Press release, The BMJ|

Study finds “important shortcomings” in official cancer drug information

Information about drugs is rarely communicated well, particularly to patients Better information is needed to aid treatment decisions Important information about cancer drug benefits, and related uncertainties, is frequently omitted from official prescription drug information sources for clinicians and patients in Europe, finds an analysis published by The BMJ today. Despite the ...

2024-06-04T10:23:39+00:0030 March 2023|Press release, The BMJ|
Go to Top